WCG Talks Trials
101 episodes - English - Latest episode: about 2 months ago - ★★★★★ - 7 ratingsInsights from leaders in clinical research and trial optimization, hosted by the WCG Clinical.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Creating Partnerships: Aligning Vendor Support for Success in Clinical Research
March 06, 2024 17:00 - 20 minutes - 14.4 MBIn the most recent episode of WCG Talks Trials, we are joined by three industry experts, Amy Thue and Shelby Ward from WCG, and Russell Lampman from Merck to discuss the topic of optimizing vendor support, and ultimately the success, of clinical trials. Listen in as we dive into feedback and perspectives from both the sponsor and vendor side of the table—for valuable take-aways and insights into how vendor support is best aligned across all stakeholders.
WCG's IRB Policy Change: Harmonizing Consent (Part 2)
February 27, 2024 21:00 - 7 minutes - 5.08 MBIn Part 2 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses new FDA regulations for waiver of consent with Kelly Fitzgerald, PhD, WCG's IRB Executive Chair and VP IBC Affairs.
WCG's IRB Policy Change: Harmonizing Consent (Part 1)
February 27, 2024 20:00 - 5 minutes - 3.55 MBIn Part 1 of this discussion, Currien MacDonald, MD, CIP Medical Chair Director for WCG's IRB, discusses a policy change that is going into effect for WCG IRB with Lindsay Abrahams, Regulatory Chair Director. Lindsay and Currien discuss the concise summary and its application to consent forms, especially for WCG.
The Ethical and Safety Considerations of Accelerating Oncology Trials
January 16, 2024 14:00 - 43 minutes - 29.7 MBIn this episode of WCG Talks Trials, our expert panel discusses various ethical, safety, and logistical challenges in accelerating clinical trials for gene and cell therapies in oncology. The conversation explores the role of Institutional Review Boards (IRBs), Institutional Biosafety Committees (IBCs), Endpoint Adjudication Committees (EACs), and Data Monitoring Committees (DMCs) in overseeing these trials, addressing issues such as patient safety, complex trial designs, and emerging biosaf...
Embarking on a Research Revolution – A Conversation with Florence Healthcare
December 18, 2023 14:00 - 30 minutes - 21.1 MBIn episode 10 of WCG Talks Trials, we are joined by Catherine Gregor, the Chief Clinical Trial Officer at Florence Healthcare, to discuss Florence’s recent Research Revolution event and the importance of site enablement in clinical research. Listen in as we recap Research Revolution, share insights on emerging clinical trial trends and innovations, and have a candid conversation about what stands in the way of successful site enablement in clinical research.
The CRA’s Evolving Role in a Postpandemic Industry
December 14, 2023 18:00 - 36 minutes - 25.3 MBIn this episode of WCG Talks Trials, we are joined by Elizabeth Weeks-Rowe, CCRA, author of The CRA’s Guide to Monitoring Clinical Research, 6th Edition. Led by WCG Director of Publications and Content, Leslie Ramsey, the discussion will delve into the ways the clinical trials industry has become more complex and technologically focused and the challenges clinical research associates (CRAs) face as monitors of clinical trials. Host: Leslie Ramsey, Director of Publications and Content, WCG ...
MAGI@home: Practical Intelligence, Real-life Examples, Actionable Information
December 04, 2023 14:00 - 29 minutes - 20.2 MBIn this episode of WCG Talks Trials, we are joined by MAGI@home Steering Committee members, Jennifer Peterson, Director, Head of Clinical Quality at M3 Wake Research, and Geoffrey Schick, Director, Strategic Site Partnerships at WCG. Led by Carmin Gade, Chief Marketing Officer at WCG, the discussion will delve into the insights and value MAGI events provide that enable attendees to achieve success in their roles and professional development.
Diversity & Inclusion with Technology in Decentralized Trials
November 22, 2023 18:00 - 1 hour - 44.7 MBThis episode of WCG Talks Trials, hosted by Kelly Fitzgerald, Executive IRB Chair and Vice President of IBC Affairs at WCG, dives into the topic of diversity and inclusion with technology in decentralized clinical trials (DCTs). The episode explores the transformative opportunities that DCTs present for addressing diversity gaps in clinical research. The discussion features a panel of experts, including Otis Johnson, former Chief Diversity, Inclusion, and Sustainability Officer at Clario; Ar...
Amplifying Patient Voices to Advance Clinical Research: The Importance of Patient Advocacy
November 13, 2023 19:00 - 29 minutes - 20.4 MBListen to the latest episode of WCG Talks Trials to hear from experts on the importance of patient advocacy in clinical research and key takeaways from WCG's 2023 Patient Forum. We'll summarize how the patient forum elevates the voices of those changing drug development for the better and recap breakthroughs and best practices shared during the most recent event. Discover more about patient and researcher collaboration, expanding diversity, equity, and inclusion in trials, and the latest ad...
The Importance of Diversity, Equity, Inclusion, and Intersectionality in Clinical Research
October 27, 2023 21:00 - 36 minutes - 25.3 MBListen to the latest episode of WCG Talks Trials to hear from experts on the importance of diversity, equity, and inclusion in clinical research and how intersectionality plays a role in promoting DE&I. We'll discuss why diversity is pivotal for comprehending the full spectrum of clinical care mechanisms and review effective DE&I strategies being deployed today. Discover how communities can be more actively engaged in clinical research and hear real-world examples of success stories in promo...
Delve into the World of Psychedelic Research and Ethical Inquiry
September 26, 2023 19:00 - 25 minutes - 17.8 MBJoin WCG Talks Trials podcast host Kelly Fitzgerald, PhD, in a riveting dialogue with guest expert Currien MacDonald, MD, as they unravel the nuances of "Psychedelics in Research: Ethical and Medical Perspectives." Dr. MacDonald, with a solid foundation in family medicine and clinical trials administration, guides listeners through a grounded exploration of psychedelic substances. In this episode, they demystify the realm of psychedelics, encompassing both dissociative and classic varietie...
A 360-degree View on Motivators and Deterrents to Clinical Trial Participation
September 11, 2023 13:00 - 30 minutes - 21 MBIn episode three of WCG Talks Trials, two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report, which provides a 360-degree view on motivators and deterrents to clinical trial participation. Listen in as we dive into feedback from perspectives across all clinical research stakeholders — sponsors, providers, sites, and patients — for valuable take-aways and insights into the trial experience. Speakers: Crissy MacDonald, PhD, Vice President, Client Delivery, WCG...
Breaking Down Enrollment Barriers: How DE&I, Technology, and Protocol Design Impact Enrollment Success
August 16, 2023 20:00 - 18 minutes - 12.7 MBIn episode two of WCG Talks Trials, we are joined by two WCG experts to discuss overcoming common enrollment challenges and how DE&I, technology, and protocol design factor into enrollment success. Listen in as we delve into the critical topic of common enrollment barriers in clinical trials, how to improve enrollment by focusing on DE&I efforts, the importance of site-centric and patient-centric technologies, and how thoughtful protocol design plays a significant role in enrollment success...
Unlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial Efficiency
July 16, 2023 10:00 - 35 minutes - 24.7 MBIn the first episode of our new podcast series, WCG Talks Trials, we are joined by three industry experts, Lisa Ballance from Virginia Commonwealth University, John Musser from Florida Cancer Specialists and Research Institute, and Dan Otap from Genentech, to discuss the topic of overcoming site challenges and addressing site burden. Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report, gain insights from our guests on solution...
Lisa LaLuna, WCG Senior VP of Patient Advocacy: Matchmaking to Save Lives
January 08, 2021 22:00 - 14 minutes - 9.9 MBLisa LaLuna has spent three decades in the pharmaceutical industry, and most of that time, she’s been focused on patient engagement and recruitment. Connecting patients to clinical trials is her passion, and in this episode, she discusses why matching patients to clinical trials is essential and how WCG is making it happen. Pharmaceutical companies want to enroll patients. Patients want trials. But too often, they aren’t connecting. CenterWatch iConnect trial finder solves this problem, s...
Lisa LaLuna, Matchmaking to Save Lives: The Clinical Trial Search Tool for Everyone
January 08, 2021 22:00 - 9 minutes - 6.65 MBFrom a career devoted to finding better ways to connect patient volunteers to clinical trials, Lisa LaLuna knows why the public needed an online search tool that is easier to use than the traditional methods of access. “Members of the public often want to find a trial to access the latest medicine, or help a family member, or just to participate as a healthy volunteer to further medical research. Pharmaceutical companies that run clinical trials of course want to enroll patients so their ...
Lisa LaLuna, Matchmaking to Save Lives: The Clinical Trial Search Tool for Everyone
January 08, 2021 22:00 - 9 minutes - 6.65 MBFrom a career devoted to finding better ways to connect patient volunteers to clinical trials, Lisa LaLuna knows why the public needed an online search tool that is easier to use than the traditional methods of access. “Members of the public often want to find a trial to access the latest medicine, or help a family member, or just to participate as a healthy volunteer to further medical research. Pharmaceutical companies that run clinical trials of course want to enroll patients so their ...
Connecting Patients to Trials: Bernadette Siddiqi of The Michael J. Fox Foundation for Parkinson’s Research
December 16, 2020 19:00 - 12 minutes - 8.59 MBBernadette Siddiqi, associate director of research partnerships at The Michael J. Fox Foundation for Parkinson’s Research talks about how they give members of the public access to the Fox Trial Finder. This clinical trial search tool that allows anyone to search for Parkinson’s disease clinical trials. More than 300 are listed on the site. It’s a bottleneck in clinical research. Patients are eager for a cure, but it can be difficult for them to connect to trials and for researchers to conne...
Connecting Patients to Trials: Bernadette Siddiqi of The Michael J. Fox Foundation for Parkinson’s Research
December 16, 2020 19:00 - 12 minutes - 8.6 MBBernadette Siddiqi, associate director of research partnerships at The Michael J. Fox Foundation for Parkinson’s Research talks about how they give members of the public access to the Fox Trial Finder. This clinical trial search tool that allows anyone to search for Parkinson’s disease clinical trials. More than 300 are listed on the site. It’s a bottleneck in clinical research. Patients are eager for a cure, but it can be difficult for them to connect to trials and for researchers to conne...
Ros Cheetham, Pharmaceutical Industry Professional, Volunteers for a COVID-19 Trial
December 01, 2020 17:00 - 15 minutes - 10.4 MBAfter more than 25 years working to plan and conduct clinical trials at pharmaceutical companies, Ros Cheetham decided to put herself into the patient role: She volunteered to participate in a COVID vaccine clinical trial. She discusses why she decided to participate in the trial and shares her experiences. So far, it’s all been positive: She speaks of modern methods, safety and the well-organized approach and thoughtful communications used by the clinical research site. She also talks abo...
On the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials Series
October 21, 2020 14:00 - 9 minutes - 6.61 MBMovement disorder trials have always been demanding. Now, sponsors face an additional challenge: How do you ensure data integrity in the era of remote clinical trials? In this podcast, Bob Dagher, MD, WCG MedAvante-ProPhase’s Chief Medical Officer, addresses this in conversation with Steve Smith, WCG President of Patient Advocacy. This is the fourth episode in our series, “Transforming CNS Trials During COVID-19—and Beyond.” Sponsors planning to restart movement disorder programs need to be...
Prostate Cancer Survivor Bryce Olson’s Message: “Sequence Me!”
October 08, 2020 19:00 - 24 minutes - 16.8 MBAs a global strategist for Intel’s Health and Life Sciences Group, Bryce Olson had an up close view of innovation happening in the lab—especially in terms of genomic sequencing and gene therapy. As a man diagnosed with aggressive stage 4 prostate cancer at 44, he had as well an up close view of how that innovation was not being translated into the clinic. He was started on a one-size-fits-all standard of care. It didn’t work, and chemo made him ill. In this podcast episode, he talks about...
On the Future of Depression Trials: Part 3 of WCG’s Transforming CNS Trials Series
September 30, 2020 18:00 - 10 minutes - 7.49 MBIn major depressive disorder, researchers have used remote assessments for decades. As a result, many of these studies have had an easier time adapting to the new clinical trial landscape. But that doesn’t mean they are pandemic-proof. So what are the critical success factors for clinical depression programs—especially now? In his conversation with WCG President of Patient Advocacy Steve Smith, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase offers his insights on...
LaTasha H. Lee, PhD, MPH: Advocating for Health Equity, Advancing Sickle Cell Disease Research
September 29, 2020 19:00 - 26 minutes - 18.3 MBLaTasha Lee, PhD, MPH’s path to becoming a sickle cell disease (SCD) researcher and policy advocate began as a child. Because the SCD trait ran in her family, she became a patient advocate while still small. Today, she is Vice President, Social and Clinical Research & Development, at the National Minority Quality Forum. In this wide-ranging interview, she touches on an array of issues affecting the SCD community. Among them: adult patients who end up in the emergency room, the increased numb...
LaTasha H. Lee, PhD, MPH: Advocating for health equity, advancing sickle cell disease research
September 29, 2020 19:00 - 26 minutes - 18.3 MBLaTasha Lee, PhD, MPH’s path to becoming a sickle cell disease (SCD) researcher and policy advocate began as a child. Because the SCD trait ran in her family, she became a patient advocate while still small. Today, she is Vice President, Social and Clinical Research & Development, at the National Minority Quality Forum. In this wide-ranging interview, she touches on an array of issues affecting the SCD community. Among them: adult patients who end up in the emergency room, the increased numb...
Jeffrey Borghoff: Finding Joy and Purpose after an Early-Onset Alzheimer’s Diagnosis
September 24, 2020 12:00 - 27 minutes - 18.8 MBAt 51, Jeffrey Borghoff was diagnosed with Alzheimer’s disease. What would devastate many people turned Borghoff into an advocate. The former software architect and developer is now a national spokesperson for the Alzheimer's Association and board member of the Greater New Jersey chapter. In this podcast, he talks about how the diagnosis forced him to reprioritize his life. “I've been pretty successful at that. I've been leading a very purposeful, engaging, joyful life.” With his care partn...
Jeffrey Borghoff: Finding Joy and Purpose after an Early-onset Alzheimer’s Diagnosis
September 24, 2020 12:00 - 27 minutes - 18.8 MBAt 51, Jeffrey Borghoff was diagnosed with Alzheimer’s disease. What would devastate many people turned Borghoff into an advocate. The former software architect and developer is now a national spokesperson for the Alzheimer's Association and board member of the Greater New Jersey chapter. In this podcast, he talks about how the diagnosis forced him to reprioritize his life. “I've been pretty successful at that. I've been leading a very purposeful, engaging, joyful life.” With his care partn...
On the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials Series
September 21, 2020 17:00 - 10 minutes - 7.32 MBRemote assessments have become a necessity across CNS trials, but some areas are more complicated than others. Schizophrenia provides one such example; the risk of variability is high, and sponsors are concerned. In this podcast, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase, sits down with WCG President of Patient Advocacy Steve Smith to discuss the topic. This is the second episode in our podcast series, “Transforming CNS Trials During COVID-19—and Beyond.” PANSS—...
Lisa Deck: Young Stroke Survivor Transforms Life-altering Challenge into Purpose-driven Advocacy for Others
September 16, 2020 14:00 - 16 minutes - 11.5 MBLisa Deck was a healthy 21-year old a week away from college graduation when her first stroke put her in the hospital. She barely made it to her graduation ceremony. She suffered two more strokes before she turned 25, and after that, a fourth stroke. After serious misdiagnosis and incorrect treatments, she was finally diagnosed with Moyamoya disease, a rare condition without a cure, but it does have a surgical treatment. In this podcast, she shares her diagnostic odyssey, her commitment t...
Lisa Deck: Young Stroke Survivor Transforms Life-Altering Challenge into Purpose-Driven Advocacy for Others
September 16, 2020 14:00 - 16 minutes - 11.5 MBLisa Deck was a healthy 21-year old a week away from college graduation when her first stroke put her in the hospital. She barely made it to her graduation ceremony. She suffered two more strokes before she turned 25, and after that, a fourth stroke. After serious misdiagnosis and incorrect treatments, she was finally diagnosed with Moyamoya disease, a rare condition without a cure, but it does have a surgical treatment. In this podcast, she shares her diagnostic odyssey, her commitment t...
The Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve Young
August 31, 2020 18:00 - 36 minutes - 20.8 MBHow can CROs and sponsors detect potential problems and issues in clinical trial conduct and data quality? That’s one of the critical issues discussed in Steve Young’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Young, Chief Scientific Officer at CluePoint, discusses how risk-based quality management (RBQM) methodology, data analytics, and data surveillance are being utilized today to go beyond just ferreting out fraud. Now, Young says, ...
Michael Poku, MD, MBA: Implements solutions to improve minority representation in clinical trials
August 28, 2020 13:00 - 21 minutes - 14.7 MBFor many of the same reasons underrepresented populations lack access to appropriate healthcare services, they are also left out of clinical trials. The problem is widely known, but solutions have been hard to come by. In this episode, Michael Poku, MD, MBA, biopharma medical director at Signify Health, explains why this is the case and then shares some approaches he and his colleagues have successfully used to remove the barriers to clinical trial participation. An important aspect is und...
Michael Poku, MD, MBA: Improving Minority Representation in Clinical Trials
August 28, 2020 13:00 - 21 minutes - 14.7 MBFor many of the same reasons underrepresented populations lack access to appropriate healthcare services, they are also left out of clinical trials. The problem is widely known, but solutions have been hard to come by. In this episode, Michael Poku, MD, MBA, biopharma medical director at Signify Health, explains why this is the case and then shares some approaches he and his colleagues have successfully used to remove the barriers to clinical trial participation. An important aspect is und...
Dana Deighton: Esophageal Cancer Patient and Persistent Activist For Her Own Survival
August 27, 2020 18:00 - 24 minutes - 17.1 MBDana Deighton, an esophageal cancer survivor, shares her diagnostic odyssey of false starts and life-threatening detours. Deighton had always been healthy—she didn’t smoke, didn’t drink and exercised every day. Then came a joint pain that wouldn’t go away, visits to numerous doctors, a series of misdiagnoses, invasive tests, and growing symptoms. The correct diagnosis of stage 4 esophageal cancer “was not the diagnosis anyone wants.” But she refused to accept physicians’ recommendations for...
Striving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art Morales
August 27, 2020 13:00 - 38 minutes - 22.3 MBCan patients be trained to report their symptoms more accurately? That’s one of the key topics discussed in Nat Katz’s and Art Morales’ interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Katz, the Chief Science Officer of WCG-Analgesic Solutions and Morales, Vice President, Technology Solutions at WCG, assert that, with proper design and implementation, you can structure clinical trials, such as pain management studies, so that patients learn ho...
Striving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art Morales
August 27, 2020 13:00 - 38 minutes - 22.3 MBCan patients be trained to report their symptoms more accurately? That’s one of the key topics discussed in Nat Katz’s and Art Morales’ interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Katz, the Chief Science Officer of WCG-Analgesic Solutions and Morales, Vice President, Technology Solutions at WCG, assert that, with proper design and implementation, you can structure clinical trials, such as pain management studies, so that patients learn ho...
The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM Technology
August 19, 2020 12:00 - 41 minutes - 24 MBHow are clinical trial companies pivoting to implement Risk-Based Quality Management programs during the pandemic? That’s one of the deep dives explored in Duncan Hall’s and Rachel Oakley’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Hall, founder and CEO of Triumph Research Intelligence (TRI) and Oakley, Vice President of RBQM Services at TRI, note that, when the COVID-19 pandemic first hit, CROs and sites performed risk assessments on t...
The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM Technology
August 19, 2020 12:00 - 41 minutes - 24 MBHow are clinical trial companies pivoting to implement Risk-Based Quality Management programs during the pandemic? That’s one of the deep dives explored in Duncan Hall’s and Rachel Oakley’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium (MCC). Hall, founder and CEO of Triumph Research Intelligence (TRI) and Oakley, Vice President of RBQM Services at TRI, note that, when the COVID-19 pandemic first hit, CROs and sites performed risk assessments on t...
Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQM
August 17, 2020 18:00 - 42 minutes - 24.3 MBWhat’s the secret to success for implementing a world-class holistic approach to a Risk-Based Quality Management (RBQM) system? That’s one of the key topics from Artem Andrianov‘s and Johanna Proeve’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. Andrianov, CEO, and Proeve, Chief Science Officer at Cyntegrity emphasize the importance of developing a clinical trial platform that enables your organization to manage the entire quality manageme...
Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQM
August 17, 2020 18:00 - 42 minutes - 24.3 MBWhat’s the secret to success for implementing a world-class holistic approach to a Risk-Based Quality Management (RBQM) system? That’s one of the key topics from Artem Andrianov‘s and Johanna Proeve’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. Andrianov, CEO, and Proeve, Chief Science Officer at Cyntegrity emphasize the importance of developing a clinical trial platform that enables your organization to manage the entire quality manageme...
Gregory L. Hall, MD: Writing the Book on Health Disparities in African Americans
July 30, 2020 19:00 - 22 minutes - 15.5 MBEver since elementary school, Gregory L. Hall, MD, knew he would be a doctor. In this interview, he shares that journey and how he came to write the book—literally—on health disparities for African Americans. His focus on disparities began more than 30 years ago with his appointment to the Ohio Commission on Minority Health—the first such commission in the country. Eventually, when he became the chairman, he had to give quarterly reports. The research he conducted on disparities for those r...
Turning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials
July 29, 2020 20:00 - 34 minutes - 19.9 MB"What impact does a remote clinical team operating model have on clinical trial performance?" That’s one of the hot topics from Ken Getz’s interview with Executive Director of WCG’s Metric Champion Consortium (MCC), Linda Sullivan, MBA. He describes several projects that the Tufts Center for the Study of Drug Development (Tufts CSDD) is currently working on; ones that will provide robust, data-driven analysis and strategic insights that help drug development professionals improve pharmaceuti...
Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs Professional
July 29, 2020 18:00 - 22 minutes - 15.3 MBLisa Carlton, PhD, understands rare childhood diseases both professionally and personally. She was already a scientist specializing in rare diseases when her daughter was diagnosed with one: tuberous sclerosis. As VP of Global Regulatory Affairs for a biotech drug developer she is involved in development of treatments for other rare diseases too. This makes her an ideal person to co-chair an industry-patient-advocacy group called the Working Group on Regulatory Science, a part of the EveryLi...
Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs Professional
July 29, 2020 18:00 - 22 minutes - 15.3 MBLisa Carlton, PhD, understands rare childhood diseases both professionally and personally. She was already a scientist specializing in rare diseases when her daughter was diagnosed with one: tuberous sclerosis. As VP of Global Regulatory Affairs for a biotech drug developer she is involved in development of treatments for other rare diseases too. This makes her an ideal person to co-chair an industry-patient-advocacy group called the Working Group on Regulatory Science, a part of the EveryLi...
Peter A. DiBiaso, MHA: Taking on the Ironman, Mount Kilimanjaro and Parkinson’s disease: a clinical trials patient recruitment expert speaks about his own life as a patient
July 29, 2020 18:00 - 19 minutes - 13.1 MBPharmaceutical executive Peter A. DiBiaso, MHA, a triathlete who has successfully completed the grueling Ironman, learned at age 49 he had early-onset Parkinson’s disease. He shares his experiences—and triumphs—in this episode. What started as a small tremor in his right hand and a stiffness in his right ankle ended up changing his life. It was a blow, but he knew what to do: The diagnosis brought his personal and professional life full circle. Five years later, he reports minimal disease...
Now Is the Time: Making Your Clinical Trial More Resilient
July 24, 2020 17:00 - 32 minutes - 18.5 MBIn this episode, host Linda Sullivan, MBA, Executive Director of WCG's Metric Champion Consortium (MCC) chats with Laurie Halloran, founder of the Halloran Consulting Group, about how she developed an on-demand drug development team that can fill in gaps in the clinical trial process for life science companies, whether these involve regulatory strategy or execution, or quality, clinical, or manufacturing issues. The COVID-19 pandemic has resulted in these companies having to pivot to more vi...
A Discussion with Linda Sullivan and Laurie Halloran on Now Is the Time: Making Your Clinical Trial More Resilient
July 24, 2020 17:00 - 32 minutes - 18.5 MBIn this episode, host Linda Sullivan, MBA, Executive Director of WCG's Metric Champion Consortium (MCC) chats with Laurie Halloran, founder of the Halloran Consulting Group, about how she developed an on-demand drug development team that can fill in gaps in the clinical trial process for life science companies, whether these involve regulatory strategy or execution, or quality, clinical, or manufacturing issues. The COVID-19 pandemic has resulted in these companies having to pivot to more vi...
Hong Liu, PhD, Making Chicago a Healthier City for Asian Americans
July 21, 2020 20:00 - 27 minutes - 19 MBTo fully engage Chicago’s medically underserved Chinese and other Asian communities and to help them address their own health issues, Dr. Hong Liu’s Midwest Asian Health Association reaches out in Mandarin, Cantonese and other languages—and does so in culturally appropriate ways. The result is better access to healthcare for many low-income, often new-immigrant minorities who experience certain health problems in higher prevalence than the general population including hepatitis, liver cance...
Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About Health
July 08, 2020 18:00 - 20 minutes - 14.3 MBIn this episode, Roslyn Daniels, the founder and president of Black Health Matters, talks about how her organization educates and motivates African-American communities about taking care of one’s own health. Seeing her own grandparents die too soon and recognizing that, in many communities, people are forced to choose between rent and healthcare, she realized that “access means nothing unless you have an understanding of the fundamentals of good health.” Using her background in media a...
Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About Health
July 08, 2020 18:00 - 20 minutes - 14.3 MBIn this episode, Roslyn Daniels, the founder and president of Black Health Matters, talks about how her organization educates and motivates African-American communities about taking care of one’s own health. Seeing her own grandparents die too soon and recognizing that, in many communities, people are forced to choose between rent and healthcare, she realized that “access means nothing unless you have an understanding of the fundamentals of good health.” Using her background in media a...